Cargando…
Impact of immunogenicity on clinical efficacy and toxicity profile of biologic agents used for treatment of inflammatory arthritis in children compared to adults
The treatment of inflammatory arthritis has been revolutionised by the introduction of biologic treatments. Many biologic agents are currently licensed for use in both paediatric and adult patients with inflammatory arthritis and contribute to improved disease outcomes compared with the pre-biologic...
Autores principales: | Parikh, Chinar R., Ponnampalam, Jaya K., Seligmann, George, Coelewij, Leda, Pineda-Torra, Ines, Jury, Elizabeth C., Ciurtin, Coziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212384/ https://www.ncbi.nlm.nih.gov/pubmed/34188697 http://dx.doi.org/10.1177/1759720X211002685 |
Ejemplares similares
-
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
por: Robinson, George, et al.
Publicado: (2022) -
Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?
por: Robinson, George A, et al.
Publicado: (2021) -
Challenges in Implementing Cardiovascular Risk Scores for Assessment of Young People With Childhood-Onset Autoimmune Rheumatic Conditions
por: Ciurtin, Coziana, et al.
Publicado: (2022) -
Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk
por: Robinson, George A., et al.
Publicado: (2022) -
CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities
por: Ciurtin, Coziana, et al.
Publicado: (2022)